InspireMD (NSPR) CEO receives 1.11M RSUs vesting 2027-2029 in three tranches

Rhea-AI Filing Summary

InspireMD, Inc. reported an equity award to its CEO and President, Marvin Slosman, in the form of 1,114,792 restricted stock units granted on January 14, 2026 at a price of $0 per unit. After this grant, he beneficially owns 3,535,658 InspireMD shares. These restricted stock units vest in three equal annual installments, with one-third vesting on each of January 14, 2027, January 14, 2028, and January 14, 2029, as long as he continues in service with the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Slosman Marvin

Role CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	1,114,792	$0.00	--

Holdings After Transaction: Restricted Stock Units — 3,535,658 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Slosman Marvin

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FL 33126

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Stock Units	01/14/2026		A		1,114,792(1)	A	$0	3,535,658	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Michael Lawless, Attorney-in-Fact for Marvin Slosman	01/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did InspireMD (NSPR) report for Marvin Slosman?

InspireMD reported that CEO and President Marvin Slosman received 1,114,792 restricted stock units on January 14, 2026 at a price of $0 per unit.

How do Marvin Slosman’s new restricted stock units at InspireMD (NSPR) vest?

The 1,114,792 restricted stock units vest in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028, and January 14, 2029, subject to his continued service.

How many InspireMD (NSPR) shares does Marvin Slosman beneficially own after this Form 4?

Following this grant, Marvin Slosman is reported to beneficially own 3,535,658 InspireMD shares.

Was Marvin Slosman’s InspireMD (NSPR) equity transaction a purchase or a grant?

The filing shows an acquisition (Code "A") of restricted stock units granted at a price of $0 per unit, indicating an equity award rather than an open-market purchase.

What is Marvin Slosman’s role at InspireMD (NSPR) according to this Form 4?

Marvin Slosman is identified as a Director and as an Officer of InspireMD, serving as CEO and President.

Is Marvin Slosman’s InspireMD (NSPR) Form 4 filed for one reporting person or multiple?

The Form 4 is indicated as being filed by one reporting person, covering Marvin Slosman’s holdings and the reported restricted stock unit grant.